FDA signs off on Merck’s cholesterol-lowering pill — the first oral treatment of its kind
The US FDA approved Merck’s cholesterol-lowering pill, it said on Thursday, the first in a class of drugs dominated by injections, which could potentially broaden the use of cholesterol medication among people at risk of heart disease. The pill, branded as Lipfendra, is intended to treat patients with hypercholesterolemia, including those with hereditary forms of the … Read more